author-photo

Jaafar Bennouna

University of Nantes

32

Papers

126

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative 18F-FDG PET/CT: Don't Forget the Thyroid!

2021 Current Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Acute ulcero-necrotic gastritis with cytomegalovirus (CMV) reactivation: an uncommon toxicity of immune checkpoint inhibitors (ICI) in a patient with microsatellite instability-high metastatic colorectal cancer (MSI-H mCRC).

2020 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma.

2020 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Pembrolizumab for the treatment of colorectal cancer

2020 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (7)
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy.

2020 Expert Review of Anticancer Therapy
Show All
- Source
- Cite
- Save
Citations (4)
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER GI-PRODIGE Trial

2019 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
The inhibitory receptor CD94/NKG2A on CD8 + tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

2019 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (17)
Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)

2018
Show All
- Source
- Cite
- Save
Citations (1)